Section one: Contracting authority
one.1) Name and addresses
Somerset NHS Foundation Trust
Musgrove Park Hospital
Taunton
TA1 5DA
Contact
Hollie Caddy
servicesteam.procurement@somersetft.nhs.uk
Country
United Kingdom
Region code
UKK23 - Somerset
Internet address(es)
Main address
https://www.somersetft.nhs.uk/
Buyer's address
https://www.somersetft.nhs.uk/
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Histopathology Reporting and MDT
two.1.2) Main CPV code
- 85111800 - Pathology services
two.1.3) Type of contract
Services
two.1.4) Short description
Provision of Digital Histopathology Reporting and MDT. Lymphoma second opinion and Bone Marrow (Trephine) reporting.
two.1.6) Information about lots
This contract is divided into lots: No
two.1.7) Total value of the procurement (excluding VAT)
Value excluding VAT: £128,208
two.2) Description
two.2.3) Place of performance
NUTS codes
- UKK23 - Somerset
two.2.4) Description of the procurement
Provision of Digital Histopathology Reporting and MDT. Lymphoma second opinion and Bone Marrow (Trephine) reporting.
The Authority is intending to award the contract to an existing provider following the direct award process C.
The lifetime value of this contract is expected to be £128,208.00
The contract dates are 14 August 2025 to 13 August 2026 with the option to extend for 12 months.
two.2.5) Award criteria
Cost criterion - Name: Existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard / Weighting: 100
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Award of a contract without prior publication of a call for competition in the cases listed below
- The procurement falls outside the scope of application of the regulations
Explanation:
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by 13 August 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: No
Section five. Award of contract
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
31 July 2025
five.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
HAEMATOPATHOLOGY ALLIANCE LTD
71-75 SHELTON STREET, COVENT GARDEN, LONDON,
London
WC2H 9JQ
Country
United Kingdom
NUTS code
- UKI53 - Redbridge and Waltham Forest
The contractor is an SME
Yes
five.2.4) Information on value of contract/lot (excluding VAT)
Initial estimated total value of the contract/lot: £128,208
Total value of the contract/lot: £128,208
Section six. Complementary information
six.3) Additional information
This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.
The decision makers were: Deputy Service Group Director - Clinical Support & Cancer Services
No conflicts of interest were declared among decision makers.
The key criteria were weighted as follows:
40% quality and Innovation
15% Value
20% Integration, Collaboration and Service Sustainability
15% Improving access, reducing health inequalities and facilitating choice
10% Social value
Quality is the most important aspect of this service as the level of expertise is extremely hard to find and essential for providing second opinions on complex cancer patients. Integration and collaboration is also essential.
The rationale for choosing the provider with reference to the key criteria:
The existing suppliers are experienced services providers with a proven track record, and they are highly likely to be able to satisfy the new contract to a sufficient standard.
six.4) Procedures for review
six.4.1) Review body
Somerset NHS Foundation Trust
Musgrove Park Hospital
Taunton
TA1 5DA
Country
United Kingdom
Internet address
https://www.somersetft.nhs.uk/
six.4.2) Body responsible for mediation procedures
NHS England
Wellington House, 133-135 Waterloo Rd
London
SE1 8UG
england.commercialqueries@nhs.net
Country
United Kingdom